Abstract |
We previously reported that ten phenylethanoid glycosides including acteoside isolated from the leaves and twigs of Callicarpa dichotoma significantly attenuated glutamate-induced neurotoxicity. In the present study, we examined anti-amnesic activity of acteoside using scopolamine-induced (1 mg/kg body weight, s.c.) amnesic mice with both passive avoidance and Morris water maze tests. Acute oral treatment (single administration prior to scopolamine treatment) of mice with acteoside (1.0, 2.5 mg/kg body weight) significantly mitigated scopolamine-induced memory deficits in the passive avoidance test. It is interesting to note that prolonged oral daily treatment of mice with much lower amount (0.1 mg/kg body weight) of acteoside for 10 d reversed the scopolamine-induced memory deficits. In the Morris water maze, prolonged oral treatment with acteoside (prolonged daily administration of 1.0 mg/kg body weight for 10 d) significantly ameliorated scopolamine-induced memory deficits showing the formation of long-term and/or short-term spatial memory. We suggest, therefore, that acteoside has anti-amnesic activity that may ultimately hold significant therapeutic value in alleviating certain memory impairment observed in Alzheimer's disease.
|
Authors | Ki Yong Lee, Eun Ju Jeong, Heum-Sook Lee, Young Choong Kim |
Journal | Biological & pharmaceutical bulletin
(Biol Pharm Bull)
Vol. 29
Issue 1
Pg. 71-4
(Jan 2006)
ISSN: 0918-6158 [Print] Japan |
PMID | 16394513
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucosides
- Muscarinic Antagonists
- Phenols
- acteoside
- Scopolamine
|
Topics |
- Animals
- Avoidance Learning
(drug effects)
- Callicarpa
(chemistry)
- Cognition
(drug effects)
- Glucosides
(pharmacology)
- Male
- Maze Learning
(drug effects)
- Memory Disorders
(chemically induced, prevention & control)
- Mice
- Mice, Inbred ICR
- Muscarinic Antagonists
(toxicity)
- Phenols
(pharmacology)
- Scopolamine
(antagonists & inhibitors, toxicity)
|